FabianaRolliniMD

PubMed

• P2YInhibition in Patients Requiring Oral Anticoagulation after Percutaneous Coronary Intervention: The SWAP-AC-2 Study.
  Luis Ortega-Paz, Wilbert Bor, Francesco Franchi, Wout W A van de Broek, Fabiana Rollini, Salvatore Giordano, Mattia Galli, Latonya Been, Ghussan Ghanem, Awss Shalhoub,...> ;JACC. Cardiovascular Interventions. 2024 Apr 1
• 2 citations
  Effect of lipid-lowering therapy on platelet reactivity in patients treated with and without antiplatelet therapy.
  Salvatore Giordano, Francesco Franchi, Fabiana Rollini, Tala Al Saleh, Ekin Uzunoglu, Francesco Costa, Dominick J Angiolillo, Luis Ortega-Paz> ;Minerva Cardiology and Angiology. 2023 Oct 23
• 2 citations
  Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: The Switching Antiplatelet-6 (SWAP-6) Study.
  Francesco Franchi, Fabiana Rollini, Luis Ortega-Paz, Latonya Been, Salvatore Giordano, Mattia Galli, Ghussan Ghanem, Haroutioun Garabedian, Tala Al Saleh, Ekin Uzunogl...> ;JACC. Cardiovascular Interventions. 2023 Oct 23
• Acute myocardial infarction following 5-fluorouracil treatment.
  Jose Rivas Rios, Melissa Oye, Yinxin Zhang, Andrea Rivas, Fabiana Rollini, Khadeeja Esmail> ;Journal of Geriatric Cardiology. 2023 Jul 28
• 21 citations
  Defining Strategies of Modulation of Antiplatelet Therapy in Patients With Coronary Artery Disease: A Consensus Document from the Academic Research Consortium.
  Davide Capodanno, Roxana Mehran, Mitchell W Krucoff, Usman Baber, Deepak L Bhatt, Piera Capranzano, Jean-Philippe Collet, Thomas Cuisset, Giuseppe De Luca, Leonardo De...> ;Circulation. 2023 Jun 20
• 3 citations
  Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti...
  Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Mattia Galli, Latonya Been, Ghussan Ghanem, Awss Shalhoub, Tiffany Ossi, Andrea Rivas, Xuan Zhou, Andres M Pineda,...> ;Thrombosis and Haemostasis. 2024 Mar 1
• 1 citations
  Clinical and Pre-Clinical Pharmacokinetics and Pharmacodynamics of Bentracimab.
  Luis Ortega-Paz, Salvatore Giordano, Francesco Franchi, Fabiana Rollini, Charles V Pollack Jr, Deepak L Bhatt, Dominick J Angiolillo> ;Clinical Pharmacokinetics. 2023 May 1
• 15 citations
  Factor XI Inhibitors in Early Clinical Trials: A Meta-analysis.
  Mattia Galli, Renzo Laborante, Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Domenico D'Amario, Davide Capodanno, Elena Tremoli, Charles Micheal Gibson, Roxana ...> ;Thrombosis and Haemostasis. 2023 Jun 1
• 1 citations
  Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with ...
  William A E Parker, Dominick J Angiolillo, Fabiana Rollini, Francesco Franchi, Marc P Bonaca, Deepak L Bhatt, Ph Gabriel Steg, Rachel C Orme, Mark R Thomas, Heather M ...> ;Vascular Pharmacology. 2023 Apr 1
• 3 citations
  Impact of evolocumab on the pharmacodynamic profiles of clopidogrel in patients with atherosclerotic cardiovascular disease: a randomised, double-blind, placebo-contro...
  Francesco Franchi, Luis Ortega-Paz, Fabiana Rollini, Latonya Been, Andrea Rivas, Naji Maaliki, Xuan Zhou, Andres M Pineda, Siva Suryadevara, Daniel Soffer, Martin Zenn...> ;Eurointervention. 2023 Mar 20
• 2 citations
  First case ofspecies isolated in pericardial fluid in an HIV and COVID-19 patient with worsening cardiac tamponade.
  Azeem Rathore, Falguni Patel, Nidhi Gupta, Denis D Asiimwe, Fabiana Rollini, Malleswari Ravi> ;Idcases. 2023 Jan 1
• 4 citations
  Dual pathway inhibition in patients with atherosclerotic disease: pharmacodynamic considerations and clinical implications.
  Mattia Galli, Francesco Franchi, Fabiana Rollini, Luis Ortega-Paz, Domenico D'Amario, Raffaele De Caterina, Roxana Mehran, C Michael Gibson, Dominick J Angiolillo> ;Expert Review of Clinical Pharmacology. 2023 Jan 1
• 9 citations
  Cangrelor in Patients With Coronary Artery Disease Pretreated With Ticagrelor: The Switching Antiplatelet (SWAP)-5 Study.
  Francesco Franchi, Luis Ortega-Paz, Fabiana Rollini, Mattia Galli, Latonya Been, Ghussan Ghanem, Awss Shalhoub, Tiffany Ossi, Andrea Rivas, Xuan Zhou, Andres M Pineda,...> ;JACC. Cardiovascular Interventions. 2023 Jan 9
• 2 citations
  Impact of diabetes mellitus on the pharmacodynamic effects of prasugrel and ticagrelor after switching from clopidogrel in patients with coronary artery disease.
  Mattia Galli, Fabiana Rollini, Latonya Been, Martin M Zenni, Dominick J Angiolillo, Francesco Franchi> ;Journal of Thrombosis and Thrombolysis. 2022 Oct 1
• 5 citations
  Pharmacokinetic and pharmacodynamic profiles of a novel phospholipid-aspirin complex liquid formulation and low dose enteric-coated aspirin: results from a prospective...
  Francesco Franchi, David J Schneider, Jayne Prats, Weihong Fan, Fabiana Rollini, Latonya Been, Heidi S Taatjes-Sommer, Deepak L Bhatt, Efthymios N Deliargyris, Dominic...> ;Journal of Thrombosis and Thrombolysis. 2022 Oct 1
• 19 citations
  Precision medicine in interventional cardiology: implications for antiplatelet therapy in patients undergoing percutaneous coronary intervention.
  Mattia Galli, Luis Ortega-Paz, Francesco Franchi, Fabiana Rollini, Dominick J Angiolillo> ;Pharmacogenomics. 2022 Aug 1
• 33 citations
  P2Yinhibitor monotherapy in patients undergoing percutaneous coronary intervention.
  Davide Capodanno, Usman Baber, Deepak L Bhatt, Jean-Philippe Collet, George Dangas, Francesco Franchi, C Michael Gibson, Hyeon-Cheol Gwon, Adnan Kastrati, Takeshi Kimu...> ;Nature Reviews. Cardiology. 2022 Dec 1
• 3 citations
  Patterns and Outcomes of Dual Antiplatelet Therapy Discontinuation After Percutaneous Coronary Intervention.
  Francesco Franchi, Fabiana Rollini> ;JACC. Cardiovascular Interventions. 2022 Apr 25
• 6 citations
  Platelet P2Y12 inhibiting therapy in adjunct to vascular dose of rivaroxaban or aspirin: a pharmacodynamic study of dual pathway inhibition vs. dual antiplatelet therapy.
  Mattia Galli, Francesco Franchi, Fabiana Rollini, Latonya Been, Patrick Abou Jaoude, Andrea Rivas, Xuan Zhou, Sida Jia, Naji Maaliki, Chang Hoon Lee, Andres M Pineda, ...> ;European Heart Journal. Cardiovascular Pharmacotherapy. 2022 Sep 29
• 22 citations
  Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.
  Mattia Galli, Stefano Benenati, Francesco Franchi, Fabiana Rollini, Davide Capodanno, Giuseppe Biondi-Zoccai, Giovanni Maria Vescovo, Larisa H Cavallari, Behnood Bikde...> ;European Heart Journal. 2022 Mar 7
• 5 citations
  Pharmacodynamic Profiles of Dual-Pathway Inhibition with or without Clopidogrel versus Dual Antiplatelet Therapy in Patients with Atherosclerotic Disease.
  Mattia Galli, Francesco Franchi, Fabiana Rollini, Latonya Been, Patrick Abou Jaoude, Andrea Rivas, Xuan Zhou, Sida Jia, Naji Maaliki, Chang Hoon Lee, Andres M Pineda, ...> ;Thrombosis and Haemostasis. 2022 Aug 1
• 21 citations
  Role of platelet function and genetic testing in patients undergoing percutaneous coronary intervention.
  Mattia Galli, Francesco Franchi, Fabiana Rollini, Dominick J Angiolillo> ;Trends in Cardiovascular Medicine. 2023 Apr 1
• 4 citations
  Impact of Timing of Pharmacodynamic Assessment on Platelet Reactivity in Patients Treated With Cangrelor.
  Francesco Franchi, Fabiana Rollini, Mattia Galli, Latonya F. Been, Ghussan Ghanem, Awss Shalhoub, Andrea Rivas, Xuan Zhou, Andres M. Pineda, Siva Suryadevara, Daniel S...> ;JACC. Cardiovascular Interventions. 2021 Nov 8
• 47 citations
  Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: A systematic review and meta...
  Luis Ortega-Paz, Mattia Galli, Davide Capodanno, Francesco Franchi, Fabiana Rollini, Behnood Bikdeli, Roxana Mehran, Gilles Montalescot, C. Michael Gibson, Renato D. L...> ;European Heart Journal. Cardiovascular Pharmacotherapy. 2021 Sep 14
• 2 citations
  Impact Of Chronic Kidney Disease On The Pharmacodynamic And Pharmacokinetic Effects Of Ticagrelor In Patients With Diabetes Mellitus And Coronary Artery Disease.
  Francesco Franchi, Fabiana Rollini, Latonya Been, Naji Maaliki, Patrick Abou Jaoude, Andrea Rivas, Xuan Zhou, Sida Jia, Maryuri Briceno, Chang Hoon Lee, Andres M. Pine...> ;European Heart Journal. Cardiovascular Pharmacotherapy. 2021 Jun 11
• Join now to see all